Patients views - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

Patients views

Description:

Patients prescribed either orlistat, sibutramine, rimonabant in the last 2 years ... loss in the short-term adapted to medication regime & managed side effects ' ... – PowerPoint PPT presentation

Number of Views:25
Avg rating:3.0/5.0
Slides: 13
Provided by: graph93
Category:

less

Transcript and Presenter's Notes

Title: Patients views


1
Patients views experiences of anti-obesity
drugs
Katie Psarou Senior Lecturer, University of
Chester Dr Ian Brown Senior Lecturer, Sheffield
Hallam University Sheffield, 25th November 2008
2
Background
  • Obesity- a public health issue
  • Available anti-obesity drugs
  • Gut
  • Orlistat- Xenical
  • Brain
  • Sibutramine- Reductil
  • Rimonabant- Acomplia

3
Aim and Methods
  • Aim to explore obese overweight patients views
    and experiences of anti-obesity drugs
  • Methods
  • Patients prescribed either orlistat, sibutramine,
    rimonabant in the last 2 years
  • Participants recruited from 3 GP practices
  • Total of 31 participants
  • Interviewed at own home/ health centre
  • Research team developed interview guide
  • Interviews took max 40mins

4
Participants Characteristics
5
Main Findings I
  • Health concerns are the key factor for seeking
    weight loss medications
  • I told him I were worried about me weight,
    obviously, I mean Ive had two heart attacks
    actually, Ive got arthritis, and the doctor
    forever telling me I ought to be losing weight.
  • Some were motivated about body image
  • I think what started it all, my friend had a
    gastric band put in she lost 7 stone and she
    started looking younger again I thought, oh God
    its my weight thats ageing me so Ill try and
    do something about my weight and - well I think
    thats what kicked it off.

6
Main Findings II
  • Most participants expected to lose weight but
    some had high expectations others were
    sceptical
  • That they would, I suppose just support what I
    was trying to do, that it would really help, not
    be a miracle cure but help.
  •  
  • Well, I expected the weight loss to be more
    dramatic than it is.
  • I think I was a bit sceptical, they dont help.

7
Main Findings III
  • Those on orlistat understood how it works but
    those on sibutramine/ rimonabant were unsure
  • Well, I think that were only if Id eaten like
    too much fat, you know. It just came out like,
    it was like somebody had dropped a drop of oil in
    toilet. But I presume thats what they were
    there to doStops your body absorbing fat so its
    got to come out somewhere, hasnt it?
  • But I never felt that sibutramine made me
    feel full ... But these have been, I just dont
    know, I didnt know how theyve worked but they
    have worked.

8
Main Findings IV
  • Participants who could observe successful weight
    loss in the short-term adapted to medication
    regime managed side effects
  • Not eating too much fat, basically. Its just
    a balanced diet. As you will know, what they
    suggest, they said get a plate, cut it in half,
    one half vegetables etc...and two of the quarters
    there, one meat and one carbohydrate...
  • Those unsure of medication effectiveness or with
    high expectations were more likely to experiment
    with regime
  • sometimes I took two of them orlistat and
    its not made no difference.

9
Main Findings V
  • Majority of participants suggested ways to
    improve health service support.
  • Id just like to think that people are getting
    the understanding and, you know, they know whats
    expected from the tablets and they know whats
    expected from them.
  • to help people even further it would be better
    if there was some kind of group maybe outside the
    doctors or maybe, I dont know, in a health
    centre or somewhere where they could go to for
    that additional support and meet other people
    that was struggling as well.

10
Implications for Practitioners I
  • Initial Assessment clarify patients perceptions
    of their obesity, reasons for seeking medical
    help expectations of anti-obesity drugs
  • Information Provision ensure clear understanding
    of medications mode of action, side effects,
    dose/regime, duration associated lifestyle
    changes
  • Quality of Ongoing Support provide fup appts
    for monitoring addressing difficulties, suggest
    other avenues for support (nurse, dietitian,
    group therapy, exercise on prescription)

11
Implications for Practitioners II
  • Transitions in Coming Off Medication be aware of
    patients weight concerns after discontinuation
    of medication guide patients to suitable
    alternative support
  • Attitudes address attitudes of primary care
    staff, if necessary, to improve patients
    perceptions about negative attitudes associated
    with obesity stereotypes

12
Thank You
  • Acknowledgements
  • Sheffield Health Social Research Consortium for
    funding support
  • Study participants for taking part
  • GP practices for helping us recruit
  • Lay representatives
  • Email k.psarou_at_chester.ac.uk
Write a Comment
User Comments (0)
About PowerShow.com